{
Torrent Pharmaceuticals Limited

Companies

}
global bisoprolol fumarate market poised for significant growth through 2032
The Global Bisoprolol Fumarate market is projected to grow from USD 1.3 billion in 2023 to USD 2.0 billion by 2032, with a CAGR of 7%. This medication, primarily used for hypertension and heart-related conditions, is expected to see increased demand driven by regulatory changes and market dynamics across various regions, particularly in Europe and Asia-Pacific. Key players include Merck, Pfizer, and Novartis, with a focus on understanding market trends and competitive strategies.
openPR.com
United States Dollar Merck & Co., Inc. Amgen Inc. Alkem Laboratories Limited Mylan Pharmaceuticals Inc. Aurobindo Pharma Limited Teva Pharmaceutical Industries Ltd Dr. Reddy's Laboratories Limited Glenmark Pharmaceuticals Limited CIPLA LTD Sandoz Group AG Pfizer Inc. Bayer AG Hikma Pharmaceuticals PLC AstraZeneca PLC Novartis AG Torrent Pharmaceuticals Limited Sanofi IND ROU BEL HUN DNK POL IDN SGP ARE BRA ZAF FRA THA MEX CZE GBR CHL AUT SAU SWE NOR NLD USA ARG MYS SVK CAN NZL LKA JPN DEU RUS KOR CHN VNM Nidhi Bhavsar Show more
Regulatory & Legal, Market Report
13:09 16.12.2024
Markets Aim for Fifth Consecutive Day of Gains with Key Stocks in Focus
Markets are poised to potentially extend their rally for a fifth consecutive day, with particular attention on Torrent Pharma and L&T. Investors are encouraged to stay updated with relevant content and transaction notifications.
Moneycontrol
L&T Torrent Pharmaceuticals Limited IND
Finance & Economy, Market Report
04:12 05.12.2024
Torrent Pharmaceuticals Acquires Three Anti-Diabetes Brands from Boehringer Ingelheim
Torrent Pharmaceuticals is set to acquire three anti-diabetes brands from Boehringer Ingelheim GmbH: Cospiaq (empagliflozin), Cospiaq Met (empagliflozin + metformin), and Xilingio (empagliflozin + linagliptin). The deal, which follows a co-marketing agreement initiated in 2022, is expected to be finalized by March 2025.
Moneycontrol
Boehringer Ingelheim International GmbH Torrent Pharmaceuticals Limited Boehringer Ingelheim India Ltd. IND DEU Show more
Healthcare, Press Release
03:09 05.12.2024
Torrent Pharma Acquires Three Anti-Diabetes Brands from Boehringer Ingelheim
Torrent Pharma is enhancing its anti-diabetes portfolio by acquiring three brands from Boehringer Ingelheim, expected to finalize in March 2025. The brands—Cospiaq, Cospiaq Met, and Xilingio—contain Empagliflozin, a key treatment for type 2 diabetes, in a market projected to grow at a 25% CAGR. This move aims to improve patient access to diabetes care in India, which is anticipated to have 12.5 crore diabetes patients by 2045.
Moneycontrol
Indian Rupee Boehringer Ingelheim KG Torrent Pharmaceuticals Limited IND Aman Mehtani Show more
Healthcare, Press Release
14:23 04.12.2024
trading insights for siemens torrent pharma and other key stocks
On Wednesday, traders are advised to consider strategies for stocks including Siemens, Torrent Pharma, Data Patterns, CAMS, PB Fintech, and LTIMindtree. Additionally, there is an option to receive push notifications for relevant content and transaction updates.
Moneycontrol
Torrent Pharmaceuticals Limited Siemens Energy AG CAMS IND Show more
Finance & Economy, Market Report
16:35 26.11.2024
torrent pharma shares gain after usfda inspection concludes with voluntary action
Torrent Pharma shares experienced an uptick following the USFDA's conclusion of an inspection at its Pithampur manufacturing facility, which was classified as 'Voluntary Action.' The inspection, conducted in the September quarter, resulted in a Form 483 with one observation.
Moneycontrol
United States Dollar Torrent Pharmaceuticals Limited IND
Regulatory & Legal, Market Report
08:40 22.11.2024
Global Market for Premature Ejaculation Treatment Expected to Reach 7.59 Billion by 2032
The global market for premature ejaculation treatment is projected to grow from $3.75 billion in 2024 to $7.59 billion by 2032, driven by increased awareness, innovative treatment options, and the impact of the COVID-19 pandemic on healthcare access. Key players like Pfizer and Eli Lilly are focusing on R&D and collaboration to enhance their market presence. Stigma and cultural barriers remain significant challenges to market growth, despite a rising acceptance of sexual health issues.
businessresearchinsights.com
Vivus Novartis AG Johnson & Johnson GLAXOSMITHKLINE CAPITAL PLC 4.0 Teva Torrent Pharmaceuticals Limited Bayer AG Sunrise Pharma Eli Lilly and Co REGENT PACIFIC Pfizer Inc. USA CAN Eli Lilly Brian Johnson Show more
Healthcare, Market Report
09:00 11.11.2024
Madhusudan Kela's wife acquires stake in Godavari Biorefineries amid market activity
Madhuri Madhusudan Kela acquired a 1.19% stake in Godavari Biorefineries Ltd by purchasing 500,000 shares at ₹335.66 each, while the company's shares closed at ₹342.85 after listing. Capri Global Capital Limited sold 374,382 shares, representing a 0.89% stake, at ₹327.98 each. Additionally, Torrent Investments offloaded 4,972,020 shares of Torrent Pharmaceuticals Ltd, leading to a 2.30% drop in the stock price, which closed at ₹3137.15.
Moneycontrol
Indian Rupee Capri Global Capital Limited Godavari Biorefineries Ltd. Torrent Pharmaceuticals Limited IND Madhusudan Kela Madhuri Madhusudan Kela Show more
Finance & Economy, Market Report
15:49 30.10.2024
torrent pharma shares fall 4 percent amid major stake sale by promoter
Torrent Pharma's shares fell by 4% on October 30, trading at Rs 3,113.25, following a block deal worth Rs 3,238.90 crore, where promoter Torrent Investments is likely the seller. Approximately 1.04 crore shares, representing a 3.1% stake, changed hands at an average price of Rs 3,108, significantly increasing trading volumes beyond the monthly average.
Moneycontrol
Indian Rupee Torrent Pharmaceuticals Limited IND
Finance & Economy, Market Report
05:09 30.10.2024
Indian equity market gains as banks drive momentum ahead of earnings reports
Indian equity markets extended gains, rising half a percent but remained below the crucial 100-day EMA of 24,475. The rally was primarily driven by banks, with experts noting that a decisive close above 24,500 is essential for further upward movement. Key stocks to watch include Marico and Torrent Pharma, while L&T and Dabur are set to report Q2 earnings today.
Moneycontrol
Dabur India Ltd. L&T Torrent Pharmaceuticals Limited Marico Limited IND Nandita Khemka Osho Krishan Deven Choksey Show more
Finance & Economy, Market Report
04:29 30.10.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Market Sentiment Analysis Corporate Responsibility & ESG Central Bank Actions Decentralized Finance (DeFi) Innovations Cryptocurrency & Blockchain Regulations Tokenomics and Crypto Economics Banking Regulations Cryptocurrency Regulations Anti-Money Laundering (AML) Regulations Market Analysis and Predictions Funding Rounds & Investments Mergers & Acquisitions Cryptocurrency Developments SEC & Financial Compliance Inflation Rates & CPI Data Real Estate Investments Shareholder Activism
Countries:
USA CHE JPN AUS CAN IND GBR DEU AUT CHN HKG RUS LIE SAU BHR FRA ARG COL FIN NLD
Companies:
Coinbase Global, Inc. Ripples USD Solana USD BlackRock, Inc. Ethereum USD NVIDIA Corporation Cardano USD Tesla, Inc. Apple Inc. Credit Suisse Real Estate Fund Siat MicroStrategy Incorporated Amazon.com, Inc. Sumitomo Corp Google Inc. Bitwise Bitcoin ETF Chainlink USD Palantir Technologies Inc. Tether USDt CNY VAT Group AG Northern Star Resources Ltd
Currencies:
United States Dollar Euro Swiss Franc Japanese Yen Australian Dollar Canadian Dollar Colombian Peso Singapore Dollar Indian Rupee
People:
Ali Martinez Donald Trump Michael J. Saylor Elon Musk Charles Hoskinson Bill Gates Fred Thiel Jack Dorsey Jacob King Brian Armstrong Aaron Green Gary Gensler Karin Keller-Sutter Mario Nawfal Alan Santana Richard Schueler Roger J. Hamilton Steven Rossi Jane Dietze Brian P. Brooks

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.